Baby, 16 Weeks, Is the Youngest to Receive Rare Lifesaving Blood Transfusion While Still in the Womb

A remarkable medical intervention has led to the survival of a baby boy in the UK who is believed to be the youngest ever recipient of an intrauterine transfusion. Baby Arthur Ransom, born in January 2025, underwent a complex procedure while still in the womb to counteract life-threatening complications resulting from parvovirus infection.

His mother, Maisie Ransom, discovered during her 16-week pregnancy that Arthur had contracted parvovirus, which can pose significant risks to unborn children. Commonly associated with mild symptoms in children such as a facial rash, the virus can lead to severe complications, such as anaemia, when transmitted to an unborn baby. This was precisely what Arthur faced, with reports indicating he developed severe anaemia that caused fluid build-up and heart failure while still gestating.

According to a recent update from the NHS Blood and Transplant (NHSBT), urgent medical action was required at St George’s Hospital in London in response to the life-threatening circumstances. Doctors carried out an intrauterine transfusion (IUT), described by the NHSBT as a rare and intricate procedure typically performed only when absolutely necessary to save a life. This transfusion involved the administration of specially prepared concentrated red blood cells directly into the unborn child’s circulatory system.

The risks associated with this procedure are considerable, primarily due to the intricate nature of delivering blood directly through the mother’s abdomen and into the umbilical cord, whilst guided by ultrasound. In Arthur’s case, medical staff first alleviated the fluid accumulation surrounding his heart before proceeding with the transfusion directly into his liver. This critical action restored proper oxygen flow, which was vital in reversing Arthur’s deteriorating condition.

Reflecting on the experience, Ms Ransom conveyed her anxiety during the ordeal, revealing that doctors had given them a 50/50 chance of survival. “The experience was absolutely terrifying,” she stated. “Without that blood, he would not have made it. His organs were failing, and if nothing was done, he would not have made it much longer.”

In a heartening turn of events, Arthur was born healthy and is now thriving, reaching all developmental milestones typical for his age. “He’s a really chirpy little boy,” Ms Ransom shared, expressing her gratitude for his progress. The family, which also includes Ms Ransom’s husband, Keith, is celebrating Arthur’s health and strength, describing him as “very handsome” and a lively addition to their lives.

The rarity of intrauterine transfusions makes Arthur’s case particularly exceptional. Dr Anne Kelly, a clinical expert in paediatric transfusion at NHSBT, emphasised the specialised nature of these procedures, which are generally conducted in select medical centres only about 200 times per year across the entire UK. Intrauterine transfusions are not typically performed until after the 18-week mark in pregnancy; hence, Arthur’s case stands out as particularly unique since he received this critical care at just 16 weeks.

Moreover, Ms Ransom expressed profound gratitude towards blood donors, whose contributions were instrumental in saving Arthur’s life. She reflected on the emotional weight of her experience, highlighting how thankful she feels for the access to advanced medical intervention and the community support that made it possible. “I don’t think there are words to describe how thankful I am to blood donors,” she remarked, recognising the vital role they played in her family’s story.

Today, Arthur’s journey to health serves as a testament to the advancements in medical treatment for unborn infants facing critical challenges. His survival not only underscores the importance of timely medical intervention but also enhances awareness of the role blood donation plays in lifesaving situations. With Arthur continuing to flourish as a spirited young boy, the message resounds clearly: the combined efforts of healthcare professionals, medical technology, and blood donors can indeed alter the course of lives in remarkable ways.